Cargando…

Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma

OBJECTIVE: To assess whether the prognostic impact of conventional risk factors and ancillary biomarkers differs across the 2 largest ProMisE molecular subgroups of endometrial carcinoma (EC). METHODS: Direct sequencing of POLE exonuclease domain hot spots and immunohistochemistry for MLH1, PMS2, MS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasanen, Annukka, Loukovaara, Mikko, Ahvenainen, Terhi, Vahteristo, Pia, Bützow, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412344/ https://www.ncbi.nlm.nih.gov/pubmed/34473724 http://dx.doi.org/10.1371/journal.pone.0253472

Ejemplares similares

Clinicopathologic vs. Molecular Integrated Prognostication of Endometrial Carcinoma by European Guidelines
por: Loukovaara, Mikko, et al.
Publicado: (2022)

Clinical factors as prognostic variables among molecular subgroups of endometrial cancer
por: Kolehmainen, Anne, et al.
Publicado: (2020)

Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Molecularly Classified Endometrial Carcinoma
por: Loukovaara, Mikko, et al.
Publicado: (2021)

Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer
por: Loukovaara, Mikko, et al.
Publicado: (2021)

MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas
por: Heikkinen, Tuomas, et al.
Publicado: (2018)

Interpretable prognostic modeling of endometrial cancer
por: Zagidullin, Bulat, et al.
Publicado: (2022)

Low Expression of Stanniocalcin 1 (STC-1) Protein Is Associated With Poor Clinicopathologic Features of Endometrial Cancer
por: Khatun, Masuma, et al.
Publicado: (2021)

3′RNA Sequencing Accurately Classifies Formalin-Fixed Paraffin-Embedded Uterine Leiomyomas
por: Mehine, Miika, et al.
Publicado: (2020)

3′RNA and whole‐genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1
por: Jokinen, Vilja, et al.
Publicado: (2022)

Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective MLH1 Methylation Analysis
por: Pasanen, Annukka, et al.
Publicado: (2022)

A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase
por: Mehine, Miika, et al.
Publicado: (2022)

Altered glycosylation of glycodelin in endometrial carcinoma
por: Hautala, Laura C., et al.
Publicado: (2020)

FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype
por: Haltia, Ulla-Maija, et al.
Publicado: (2014)

Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer
por: Ukkola, Iiris, et al.
Publicado: (2021)

Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017)

Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer
por: Raffone, Antonio, et al.
Publicado: (2021)

Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors
por: Mäkinen, Netta, et al.
Publicado: (2017)

Combination of Proactive Molecular Risk Classifier for Endometrial cancer (ProMisE) with sonographic and demographic characteristics in preoperative prediction of recurrence or progression of endometrial cancer
por: Eriksson, L. S. E., et al.
Publicado: (2021)

Molecular Classification in Patients With Endometrial Cancer After Fertility-Preserving Treatment: Application of ProMisE Classifier and Combination of Prognostic Evidence
por: Ran, Xuting, et al.
Publicado: (2022)

Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
por: Mäkinen, Netta, et al.
Publicado: (2016)

Validation and Analysis of a Multi-site MIS Prospective Registry Through Sub-analysis of an MIS TLIF Subgroup
por: Sclafani, Joseph A., et al.
Publicado: (2014)

Global metabolomic profiling of uterine leiomyomas
por: Heinonen, Hanna-Riikka, et al.
Publicado: (2017)

BACH1 Ser919Pro variant and breast cancer risk
por: Vahteristo, Pia, et al.
Publicado: (2006)

Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas
por: Välimäki, Niko, et al.
Publicado: (2023)

Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups
por: Kohe, Sarah, et al.
Publicado: (2015)

Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
por: Kolterud, Åsa, et al.
Publicado: (2022)

Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness
por: Karvonen, Hanna, et al.
Publicado: (2020)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma
por: Ruscelli, Martina, et al.
Publicado: (2023)

Clinicopathological Survey of 204 Rosacea Patients Regarding Rosacea Subgroups and Severity
por: Ghanadan, Alireza, et al.
Publicado: (2023)

Mis días y mis noches
por: Julie
Publicado: (1975)

Pediatric dermatofibrosarcoma protuberans: A clinicopathologic and genetic analysis of 66 cases in the largest institution in Southwest China
por: Zhang, Zhang, et al.
Publicado: (2023)

Clinicopathological roles of adiponectin and leptin receptors in endometrial carcinoma
por: YABUSHITA, HIROMITSU, et al.
Publicado: (2014)

Candidate Biomarkers for Genetic and Clinicopathological Diagnosis of Endometrial Cancer
por: Banno, Kouji, et al.
Publicado: (2013)

Clinicopathologic features of endometrial cancer with mismatch repair deficiency
por: Gordhandas, Sushmita, et al.
Publicado: (2020)

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
por: Zhu, Qing, et al.
Publicado: (2022)

Level of evidence for promising subgroup findings in a negative trial
por: Tanniou, Julien, et al.
Publicado: (2013)

Psychosis related to neurological conditions: pro and cons of the dis- / mis-connectivity models of schizophrenia
por: Foucher, Jack R., et al.
Publicado: (2006)

Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups
por: Gupta, Kirti, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s76fdk8d8eo3b5uo372ai1mhh2